A detailed history of Creative Planning transactions in Xencor Inc stock. As of the latest transaction made, Creative Planning holds 18,130 shares of XNCR stock, worth $256,176. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,130
Previous 14,469 25.3%
Holding current value
$256,176
Previous $153,000 7.19%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

BUY
$7.52 - $11.26 $27,530 - $41,222
3,661 Added 25.3%
18,130 $142,000
Q1 2025

May 15, 2025

BUY
$10.64 - $24.13 $153,258 - $347,568
14,404 Added 22160.0%
14,469 $153,000
Q4 2024

Feb 14, 2025

SELL
$19.43 - $26.84 $233,742 - $322,885
-12,030 Reduced 99.46%
65 $1,000
Q3 2024

Oct 11, 2024

SELL
$15.7 - $21.65 $51,182 - $70,579
-3,260 Reduced 21.23%
12,095 $243,000
Q2 2024

Aug 15, 2024

SELL
$18.21 - $24.5 $61,112 - $82,222
-3,356 Reduced 17.94%
15,355 $290,000
Q1 2024

May 10, 2024

BUY
$18.65 - $26.52 $84,726 - $120,480
4,543 Added 32.07%
18,711 $414,000
Q4 2023

Feb 14, 2024

BUY
$16.53 - $21.42 $234,197 - $303,478
14,168 New
14,168 $300,000
Q4 2017

Jan 17, 2018

SELL
$19.29 - $24.83 $721,446 - $928,641
-37,400 Closed
0 $0
Q3 2017

Oct 17, 2017

BUY
$19.61 - $23.35 $733,414 - $873,290
37,400
37,400 $857,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $844M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.